Vident Advisory’s Biohaven BHVN Stock Holding History

Vident Advisory’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,284	Closed	-$271K	–	1613
2025 Q1	$271K	Buy	+11,284	New	+$398K	﹤0.01%	1314

Other funds holding BHVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vident Advisory's BHVN Position: Q2 2025 in Review

Vident Advisory sold out of Biohaven (BHVN) in Q2 2025, closing a stake of 11,284 shares — an estimated $271K sold.

Vident Advisory first reported a position in BHVN in Q1 2025 and held it in 1 quarter. The position peaked at $271K in Q1 2025. 249 funds tracked by Wall St. Rank hold BHVN as of Q2 2025.

Vident Advisory reported no remaining Biohaven position as of Q2 2025 after selling out during the quarter.
Vident Advisory sold 11,284 Biohaven shares in Q2 2025, an estimated $271K.
Vident Advisory first reported a position in Biohaven in Q1 2025 and held it in 1 quarter.
Vident Advisory's Biohaven position peaked at $271K in Q1 2025.
249 funds tracked by Wall St. Rank held Biohaven as of Q2 2025.

Based on Vident Advisory's 13F filing for Q2 2025, filed 14 Aug 2025.